Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Merck and Isis scientists describe new agents for hepatitis C with NS5B-based mechanism

April 14, 2003

Enema formulation of alicaforsen assessed in new phase II ulcerative colitis trial

April 11, 2003

Zadaxin combination therapy demonstrates sustained response in hepatitis B patients

April 11, 2003

Preliminary phase II results for RDP-58 in ulcerative colitis and Crohn's disease

April 11, 2003

Pegasys more effective than interferon in difficult-to-treat hepatitis B

April 11, 2003

Pharmacokinetic/pharmacodynamic modeling for proton pump inhibitor YH-1885

April 9, 2003

Solvay claims new NK2 antagonists with utility in irritable bowel syndrome therapy

April 9, 2003

Postmarketing Visicol study begins patient treatment

April 8, 2003

Hepavir B enters clinical testing

April 8, 2003

Effects of etiprednol dicloacetate on the HPA axis

April 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...